The structural stability of plasmepsin II from Plasmodium falciparum

被引:0
|
作者
Nezami, A [1 ]
Freire, E [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
1745Pos
引用
收藏
页码:295A / 295A
页数:1
相关论文
共 50 条
  • [21] A novel compound purified from Alstonia boonei inhibits Plasmodium falciparum lactate dehydrogenase and plasmepsin II
    Olanlokun, John Oludele
    Olotu, Andrew Fisayo
    David, Oluwole Moses
    Idowu, Thomas Oyebode
    Soliman, ElSayed Mahmoud
    Olorunsogo, Olufunso Olabode
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (08): : 2193 - 2200
  • [22] Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine
    Loesbanluechai, Duangkamon
    Kotanan, Namfon
    de Cozar, Cristina
    Kochakarn, Theerarat
    Ansbro, Megan R.
    Chotivanich, Kesinee
    White, Nicholas J.
    Wilairat, Prapon
    Lee, Marcus C. S.
    Javier Gamo, Francisco
    Maria Sanz, Laura
    Chookajorn, Thanat
    Kumpornsin, Krittikorn
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2019, 9 : 16 - 22
  • [23] Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes
    Nöteberg, D
    Hamelink, E
    Hultén, J
    Wahlgren, M
    Vrang, L
    Samuelsson, B
    Hallberg, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (05) : 734 - 746
  • [24] Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents
    Boss, C
    Richard-Bildstein, S
    Weller, T
    Fischli, W
    Meyer, S
    Binkert, C
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (11) : 883 - 907
  • [25] Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
    Inoue, Juliana
    Silva, Miguel
    Fofana, Bakary
    Sanogo, Kassim
    Martensson, Andreas
    Sagara, Issaka
    Bjorkman, Anders
    Veiga, Maria Isabel
    Ferreira, Pedro Eduardo
    Djimde, Abdoulaye
    Gil, Jose Pedro
    EMERGING INFECTIOUS DISEASES, 2018, 24 (08) : 1591 - 1593
  • [26] Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum
    Xiao, Huogen
    Tanaka, Takuji
    Ogawa, Masahiro
    Yada, Rickey Y.
    PROTEIN ENGINEERING DESIGN & SELECTION, 2007, 20 (12): : 625 - 633
  • [27] Expression and Purification of Functionally Active Recombinant Plasmepsin 9 from Plasmodium falciparum
    Olajuyigbe, Folasade M.
    PROTEIN SCIENCE, 2014, 23 : 74 - 74
  • [28] Structural Plasticity of Plasmodium falciparum Plasmepsin X to Accommodate Binding of Potent Macrocyclic Hydroxyethylamine Inhibitors
    Withers-Martinez, Chrislaine
    George, Roger
    Ogrodowicz, Roksana
    Kunzelmann, Simone
    Purkiss, Andrew G.
    Kjaer, Svend
    Walker, Philip A.
    Kovada, Vadims
    Jirgensons, Aigars
    Blackman, Michael J.
    JOURNAL OF MOLECULAR BIOLOGY, 2025, 437 (10)
  • [29] EXAMINING THE EPISTATIC INTERACTION BETWEEN PLASMEPSIN II AND PFCRT IN PLASMODIUM. FALCIPARUM PIPERAQUINE RESISTANCE
    Mok, Sachel
    Ross, Leila
    Dhingra, Satish
    Yeo, Tomas
    Shears, Melanie
    Tripathi, Abhai K.
    Musset, Lise
    Sinnis, Photini
    Fidock, David A.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 476 - 476
  • [30] C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II:: Synthesis and theoretical predictions
    Ersmark, K
    Feierberg, I
    Bjelic, S
    Hultén, J
    Samuelsson, B
    Åqvist, J
    Hallberg, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (17) : 3723 - 3733